Oncotype-DX is a genetic test for breast cancer that predicts the risk of recurrence. It costs about $3,500 and is covered by the majority of U.S. health plans. The test determines, based on the patient's genes and the genes of the cancer, the likelihood of the cancer coming back within 10 years. It can help the patient and oncologist figure out if they should treat the cancer with chemotherapy